Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Objectives: Approximately 5–10% of patients presenting for percutaneous coronary intervention (PCI) have concurrent atrial fibrillation (AF). To what extent AF portends adverse long-term outcomes in these patients remains to be defined. Methods: We analysed data from the multicentre Melbourne Interv...

Full description

Bibliographic Details
Main Authors: Batchelor, R.J., Dinh, D., Noaman, S., Brennan, A., Clark, D., Ajani, A., Freeman, M., Stub, D., Reid, Christopher, Oqueli, E., Yip, T., Shaw, J., Walton, A., Duffy, S.J., Chan, W.
Format: Journal Article
Language:English
Published: ELSEVIER SCIENCE INC 2022
Subjects:
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Atrial fibrillation
Acute coronary syndrome
Percutaneous coronary intervention
Clinical outcomes
WARFARIN
IMPACT
RISK
RIVAROXABAN
ASSOCIATION
DABIGATRAN
APIXABAN
DISEASE
TRIALS
Atrial Fibrillation
Hemorrhage
Humans
Myocardial Infarction
Percutaneous Coronary Intervention
Registries
Treatment Outcome
Online Access:http://purl.org/au-research/grants/nhmrc/1111170
http://hdl.handle.net/20.500.11937/93765

Internet

http://purl.org/au-research/grants/nhmrc/1111170
http://hdl.handle.net/20.500.11937/93765

Similar Items